Is Shah Capital’s Criticism of Novavax Fair? A Wall Street Analyst Weighs InNews DeskApril 19, 20260 In May 2024, Shah Capital, a hedge fund in North Carolina, withdrew from its proxy fight against Novavax’s board of…